Nephrology News
Tolvaptan Offers Sustained Slowing of Renal Function Decline in ADPKD
Open-label extension study confirms disease-modifying effect on eGFR, but not total kidney volume growth.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/